Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation
Mustapha Abubakar, Montserrat García‐Closas(Institute of Cancer Research), Minouk J. Schoemaker(Institute of Cancer Research), Marjanka K. Schmidt(University of Cambridge), Mark E. Sherman(Mayo Clinic in Florida), Stephen M. Hewitt(National Institutes of Health), Nilanjan Chatterjee(Johns Hopkins University), Penny Coulson(Institute of Cancer Research), Fergus J. Couch(Mayo Clinic), Frances Daley(Breast Cancer Now), Jenny Chang‐Claude(Universität Hamburg), Michael E. Jones(Institute of Cancer Research), Jonine D. Figueroa, Anthony J. Swerdlow(Institute of Cancer Research), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Roger L. Milne(The University of Melbourne), H. Raza Ali(University of Zurich), Peter Devilee(Leiden University), Douglas F. Easton(University of Cambridge), Javier Benı́tez(Spanish National Cancer Research Centre), Antoinette Hollestelle(Erasmus MC Cancer Institute), Maartje J. Hooning(Erasmus MC Cancer Institute), Fiona M. Blows(University of Cambridge), Renske Keeman(The Netherlands Cancer Institute), Hermann Brenner(Universidad de Granada), Anja Rudolph(Institut für Qualität im Management (Germany)), Linetta B. Koppert(Erasmus MC Cancer Institute), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Qin Wang(University of Cambridge), Caroline Seynaeve(Radboud University Nijmegen), Christa Stegmaier(Karolinska University Hospital), Renée Foekens(Erasmus MC Cancer Institute), kConFab Investigators, Jolanta Lissowska, Manjeet K. Bolla(University of Cambridge), Hans‐Peter Sinn(Heidelberg University)
Cited by 33
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k